Antihistamine Price Erosion Justifies Forced Switch – WellPoint
This article was originally published in The Tan Sheet
Executive Summary
WellPoint Health Networks is continuing its campaign to urge a forced Rx-to-OTC switch of low-and non-sedating antihistamines cetirizine, fexofenadine and desloratadine